This was a collaborative biomarker study of RWD from CGP testing (Foundation Medicine, Inc). Hybrid capture was conducted on at least 324 cancer-related genes and select introns from up to 31 genes ...

Four oral sessions to be presented, including validation data for Shield MCD test, selected for highly anticipated NCI Vanguard Study 18 total abstracts to showcase significant developments in ...

According to clinical guidelines, high-risk myeloma patients should receive intensified treatment regimens. However, heterogeneity in clinical markers and staging systems lead to various ...